InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by ARONSTAM PETER, Chief Financial Officer. Director active across 1 company, notably Cytocom, Inc.. Aggregated, 2 disclosures have been recorded. History available since 27 July 2021. The latest transaction was disclosed on 27 July 2021 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
141,370 shares0Common Stock, par value $0.005 per shareSEC:0001437749-21-017950
141,370 shares0Common Stock, par value $0.005 per shareSEC:0001437749-21-017950:0
2 of 2 declarations
About ARONSTAM PETER
ARONSTAM PETER is Chief Financial Officer at Cytocom, Inc. In this role, he is responsible for financial management and budgeting strategy for the company. His expertise in finance allows him to optimize financial performance and ensure regulatory compliance. Peter plays a key role in strategic planning and financial results analysis.
